| RS2046162412 |
CLN3
|
Health Risk |
Pathogenic |
— |
| RS2046218391 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 |
| RS2046221354 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 |
| RS2046226928 |
VPS13C
|
Health Risk |
Likely pathogenic |
Autosomal recessive early-onset Parkinson disease 23, Autosomal recessive early-onset Parkinson disease 23 |
| RS2046240661 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2046243804 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2046246646 |
KANSL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2046256329 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046258303 |
TRAPPC2
|
Health Risk |
Pathogenic |
— |
| RS2046260021 |
KANSL1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2046260727 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2046278091 |
KANSL1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2046279070 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS2046281324 |
TRAPPC2
|
Health Risk |
Pathogenic |
— |
| RS2046290303 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS2046303697 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2046303728 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2046314714 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS2046363256 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCC6-related disorder, ABCC6-related disorder |
| RS2046386900 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2046392476 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046415471 |
ITPR1
|
Health Risk |
Likely pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS2046440702 |
TNFRSF11A
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS2046499843 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2046510028 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2046512154 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046518776 |
TYMS
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, digenic |
| RS2046521710 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046539116 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2046575698 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2046581341 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2046598826 |
TANC2
|
Health Risk |
Likely pathogenic |
Epilepsy, Epilepsy |
| RS2046600751 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2046600889 |
TIMP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2046607104 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2046633903 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046675157 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2046702287 |
NALCN
|
Health Risk |
Likely pathogenic |
Hypotonia, infantile |
| RS2046704290 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046705692 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046707580 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2046707868 |
NEDD4L
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 7, Periventricular nodular heterotopia 7 |
| RS2046713136 |
KDM6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2046732267 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2046739414 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2046750269 |
TANC2
|
Health Risk |
Likely pathogenic |
Developmental delay, Developmental delay |
| RS2046752611 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046761831 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2046773175 |
TANGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome, Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome |
| RS2046773972 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2046778426 |
ABCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2046802180 |
TCF4
|
Health Risk |
Likely pathogenic |
— |
| RS2046802842 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2046807248 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046807371 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2046815679 |
FLCN
|
Health Risk |
Likely pathogenic |
— |
| RS2046823775 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2046824297 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2046827455 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046832726 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046833026 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046836342 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2046836692 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046837806 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046843049 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046860754 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046866025 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2046877798 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2046880504 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome 1 |
| RS2046884079 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2046888772 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2046893100 |
VPS13C
|
Health Risk |
Likely pathogenic |
Young-onset Parkinson disease, Young-onset Parkinson disease |
| RS2046896882 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS2046897026 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046897213 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046897246 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS2046897516 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046897646 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2046899820 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046900264 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2046907170 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046907944 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2046921766 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2046922813 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2046925676 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2046925963 |
NOTCH3
|
Health Risk |
Pathogenic |
NOTCH3-related disorder, NOTCH3-related disorder |
| RS2046926886 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2046927630 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2046928465 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2046928618 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046929318 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2046931673 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Lateral meningocele syndrome, Myofibromatosis |
| RS2046931882 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2046932414 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046932510 |
OBSCN
|
Health Risk |
Pathogenic |
— |
| RS2046933681 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy |
| RS2046934287 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2046934971 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046935167 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2046935672 |
NOTCH3
|
Health Risk |
Pathogenic |
— |